Literature DB >> 7554142

Effects of lysophosphatidic acid, a novel lipid mediator, on cytosolic Ca2+ and contractility in cultured rat mesangial cells.

C N Inoue1, H G Forster, M Epstein.   

Abstract

Lysophosphatidic acid (LPA), the smallest and structurally simplest phospholipid, has the potential to modulate cellular signaling in diverse tissues and cell types, including fibroblasts. In the present study, we assessed the effects of LPA on cultured rat glomerular mesangial cells. Quantitative changes of [Ca2+]i in response to LPA were measured in monolayers of mesangial cells loaded with the fluorescent Ca2+ indicator fura 2. LPA (10 nmol/L to 100 mumol/L) increased [Ca2+]i in a dose-dependent manner and evoked inositol trisphosphate formation. LPA (1 mumol/L to 30 mumol/L) also elicited a marked, albeit transient, contractile response in mesangial cells cultured on collagen gel, as assessed by a decrease in cell surface area (CSA). The contraction persisted for 5 minutes (CSA decreased by 31%), whereupon the mesangial cells gradually relaxed with a consequent increase in CSA. Pretreatment of mesangial cells with isradipine (1 mumol/L), a dihydropyridine-sensitive Ca2+ channel blocker, completely blocked LPA-induced contraction. Isradipine also decreased resting [Ca2+]i levels as well as the peak and the subsequently sustained [Ca2+]i levels induced by LPA, suggesting that the contractile effects of LPA are dependent on Ca2+ entry through voltage-gated Ca2+ channels. Finally, LPA stimulated an increase in both prostaglandin E2 synthesis and cAMP accumulation, indicating that these mediators may modulate the contractile effects of LPA. Our study is the first demonstration that exogenous LPA induces mesangial cell contraction and suggests that the contraction is mediated by mobilization of intracellular Ca2+ by activation of the phosphoinositide cascade as well as by promotion of Ca2+ entry across the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554142     DOI: 10.1161/01.res.77.5.888

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Roles of atypical protein kinase C in lysophosphatidic acid-induced type II adenylyl cyclase activation in RAW 264.7 macrophages.

Authors:  W W Lin; S H Chang; S M Wang
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins.

Authors:  C O Reiser; T Lanz; F Hofmann; G Hofer; H D Rupprecht; M Goppelt-Struebe
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

3.  Lysophosphatidic acid-sensitive intracellular Ca2+ store does not regulate Ca2+ entry at plasma membrane in Jurkat human T-cells.

Authors:  H Takemura; K Imoto; S Sakano; M Kaneko; H Ohshika
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

4.  Activatory properties of lysophosphatidic acid on human THP-1 cells.

Authors:  F D'Aquilio; M Procaccini; V Izzi; V Chiurchiu'; V Giambra; F Carotenuto; P Di Nardo; P M Baldini
Journal:  Inflammation       Date:  2006-11-07       Impact factor: 4.092

Review 5.  Lysophosphatidic acid and renal fibrosis.

Authors:  Jean-Philippe Pradère; Julien Gonzalez; Julie Klein; Philippe Valet; Sandra Grès; David Salant; Jean-Loup Bascands; Jean-Sébastien Saulnier-Blache; Joost P Schanstra
Journal:  Biochim Biophys Acta       Date:  2008-04-11

6.  Activatory properties of lysophosphatidic acid on human THP-1 cells.

Authors:  F D'Aquilio; M Procaccini; V Izzi; V Chiurchiu'; V Giambra; F Carotenuto; P Di Nardo; P M Baldini
Journal:  Inflammation       Date:  2007-10       Impact factor: 4.092

7.  Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.

Authors:  Takashi Hirata; Stanley V Smith; Teisuke Takahashi; Noriyuki Miyata; Richard J Roman
Journal:  J Pharmacol Exp Ther       Date:  2020-12-04       Impact factor: 4.030

8.  Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare.

Authors:  Anna Szóstek-Mioduchowska; Natalia Leciejewska; Beata Zelmańska; Joanna Staszkiewicz-Chodor; Graça Ferreira-Dias; Dariusz Skarzynski
Journal:  BMC Vet Res       Date:  2020-09-17       Impact factor: 2.741

Review 9.  Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract.

Authors:  Izabela Wocławek-Potocka; Paulina Rawińska; Ilona Kowalczyk-Zieba; Dorota Boruszewska; Emilia Sinderewicz; Tomasz Waśniewski; Dariusz Jan Skarzynski
Journal:  Mediators Inflamm       Date:  2014-03-12       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.